Nanoparticle delivery of siRNA against TWIST to reduce drug resistance and tumor growth in ovarian cancer models

Cancer statistics, 2016

Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2016 · 16.2K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis

Jing Yang, Sendurai A. Mani, Joana Liu Donaher et al. · Cell · 2004 · 3.8K citations · Full text

Medicine, Cancer Biology, Developmental Biology +16

Evaluating cell lines as tumour models by comparison of genomic profiles

Silvia Domcke, Rileen Sinha, Douglas A. Levine et al. · Nature Communications · 2013 · 1.5K citations · Full text

Medicine, Genetics, Oncology +14

Mesoporous Silica Nanoparticles as a Delivery System for Hydrophobic Anticancer Drugs

Jie Lü, Monty Liong, Jeffrey I. Zink et al. · Small · 2007 · 1K citations

Pharmacy, Pharmaceutics, Pharmacology +12

The Tubal Fimbria Is a Preferred Site for Early Adenocarcinoma in Women With Familial Ovarian Cancer Syndrome

Fabíola Medeiros, Michael G. Muto, Yonghee Lee et al. · The American Journal of Surgical Pathology · 2006 · 919 citations

Medicine, Gynecology, Pathology +17